Bristol-Myers Squibb (NYSE:BMY – Get Free Report)’s stock price reached a new 52-week low during trading on Tuesday . The company traded as low as $42.95 and last traded at $43.06, with a volume of 1932146 shares traded. The stock had previously closed at $43.36. Wall Street Analysts Forecast Growth BMY has been the topic […]
Princeton Capital Management LLC reduced its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 13.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,660 shares of the biopharmaceutical company’s stock after selling 1,172 shares during the period. Princeton Capital Management […]
Shares of Bristol-Myers Squibb (NYSE:BMY – Get Free Report) dropped 1.6% on Thursday . The company traded as low as $43.80 and last traded at $43.84. Approximately 3,596,410 shares changed hands during trading, a decline of 77% from the average daily volume of 15,412,625 shares. The stock had previously closed at $44.55. Analysts Set New […]
Bristol-Myers Squibb (NYSE:BMY – Get Free Report)’s stock price was down 1.6% during mid-day trading on Thursday . The stock traded as low as $43.80 and last traded at $43.84. Approximately 3,596,410 shares changed hands during mid-day trading, a decline of 77% from the average daily volume of 15,412,625 shares. The stock had previously closed […]
Great Lakes Advisors LLC lowered its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 26.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,260,589 shares of the biopharmaceutical company’s stock after selling 457,616 shares during the period. Great Lakes […]